Accredited Investors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$382K Hold
4,377
0.02% 160
2025
Q1
$299K Hold
4,377
0.02% 176
2024
Q4
$340K Sell
4,377
-130
-3% -$10.1K 0.02% 169
2024
Q3
$302K Hold
4,507
0.02% 176
2024
Q2
$511K Sell
4,507
-136
-3% -$15.4K 0.03% 121
2024
Q1
$644K Buy
4,643
+130
+3% +$18K 0.04% 109
2023
Q4
$560K Hold
4,513
0.04% 114
2023
Q3
$421K Hold
4,513
0.03% 124
2023
Q2
$580K Sell
4,513
-389
-8% -$50K 0.04% 102
2023
Q1
$570K Hold
4,902
0.04% 101
2022
Q4
$555K Buy
4,902
+2
+0% +$226 0.05% 98
2022
Q3
$395K Sell
4,900
-100
-2% -$8.06K 0.05% 111
2022
Q2
$373K Sell
5,000
-8
-0.2% -$597 0.04% 118
2022
Q1
$641K Buy
5,008
+16
+0.3% +$2.05K 0.06% 96
2021
Q4
$670K Hold
4,992
0.06% 96
2021
Q3
$682K Sell
4,992
-108
-2% -$14.8K 0.07% 86
2021
Q2
$544K Sell
5,100
-228
-4% -$24.3K 0.06% 101
2021
Q1
$479K Sell
5,328
-1,012
-16% -$91K 0.06% 99
2020
Q4
$586K Hold
6,340
0.1% 86
2020
Q3
$653K Sell
6,340
-284
-4% -$29.3K 0.14% 72
2020
Q2
$671K Sell
6,624
-464
-7% -$47K 0.14% 70
2020
Q1
$477K Sell
7,088
-1,616
-19% -$109K 0.11% 80
2019
Q4
$476K Hold
8,704
0.08% 88
2019
Q3
$325K Hold
8,704
0.06% 105
2019
Q2
$326K Sell
8,704
-500
-5% -$18.7K 0.06% 105
2019
Q1
$274K Buy
9,204
+772
+9% +$23K 0.06% 110
2018
Q4
$253K Sell
8,432
-1,036
-11% -$31.1K 0.06% 104
2018
Q3
$339K Hold
9,468
0.08% 85
2018
Q2
$225K Buy
+9,468
New +$225K 0.06% 105
2017
Q2
Sell
-9,468
Closed -$201K 110
2017
Q1
$201K Buy
+9,468
New +$201K 0.05% 103
2016
Q4
Sell
-9,468
Closed -$207K 100
2016
Q3
$207K Buy
+9,468
New +$207K 0.06% 91
2015
Q4
Sell
-9,468
Closed -$204K 91
2015
Q3
$204K Buy
+9,468
New +$204K 0.05% 80